(917) 310-3371
Manhattan
StuyTown
259 1st Ave, New York, NY 10003
A Manhattan location for addiction medicine visits, medication follow-up, and structured treatment planning.
View local MAT details Get directions
Coverage depends on your exact plan, clinician, location and service. Check participation and expected charges with the clinic and your insurer before booking.
Patients can start with a local clinic, telemedicine when appropriate, or a focused next step for Medicaid, same-day access, bridge review, or fentanyl-specific planning.
Confirm the specific service at the intended site before traveling. Ask which part of evaluation and follow-up takes place there, how to arrange it and whether your chosen treatment is available at that location.
Ask whether the site provides buprenorphine evaluation, a particular depot injection, naltrexone assessment or referral. Methadone for OUD generally uses an opioid treatment program. A general OUD location listing should lead to the appropriate service rather than assuming every option is administered there.
Bring treatment records, the last medicine or injection and urgent access concerns. Confirm where ongoing prescribing, injections and behavioral care occur and who manages a gap. If symptoms need another level of care, ask for the appropriate assessment pathway instead of waiting for a routine visit.
Treatment for opioid use disorder starts with an assessment of opioid use, withdrawal, overdose risk and what you want to change. Medicines can reduce withdrawal or cravings and help protect recovery. Treatment can be appropriate after heroin, fentanyl, nonprescribed pills or problematic prescription opioid use. An evaluation is still useful if you are uncertain about the diagnosis or have returned to use after earlier treatment.
Buprenorphine and methadone activate opioid receptors in controlled ways; naltrexone blocks them and requires an opioid-free starting point. They have different entry requirements and do not offer an identical experience. Naloxone reverses an opioid overdose but is not ongoing OUD treatment. Withdrawal management by itself does not resolve the longer-term risk of relapse and overdose.
The clinician reviews frequency and route of use, loss of control, consequences, tolerance and withdrawal, while distinguishing prescribed use and physical dependence from OUD. Pregnancy, severe symptoms, intoxication, other substance use and health conditions affect the safest setting. Bring any current OUD prescription: transferring care does not necessarily mean starting over, but records and an assessment are needed.
Describe the last opioid use, uncertain pill contents, prior overdoses and current symptoms. Include alcohol, sedatives, stimulants and pain treatment. The clinician assesses whether an outpatient plan is safe or whether urgent, hospital or another level of care is needed. An overdose or unstable condition should not wait for an ordinary clinic appointment.
Compare buprenorphine, methadone and naltrexone against your clinical needs and preferences. Buprenorphine initiation needs a safe plan after recent opioid exposure. Methadone for OUD generally requires an opioid treatment program. Naltrexone requires detoxification and opioid-free assessment. A clinic should help with a suitable referral when the chosen treatment is outside its verified services.
Clarify formulation, pharmacy or injection logistics, return visits, monitoring and whom to call for access problems. Address pain and mental-health treatment at the same time. Discuss counseling, recovery support and barriers such as transportation, housing or work hours without assuming one service can provide every resource.
Have naloxone and an overdose-response plan. Identify what to do after missed medication, renewed use or hospital discharge. A return to use needs reassessment of symptoms, dose coverage and other risks; it should not be hidden because you fear the visit will be wasted.
Bring identification if required for registration, a medication list, pharmacy details, recent treatment records and relevant insurance information. Tell the clinician if you are nearly out of medication or cannot obtain it. Ask how the first prescription or injection is arranged and what follow-up is required. Do not take borrowed treatment or create an opioid-free interval without advice to prepare for the visit.
Call 911 for possible overdose, slow breathing, unresponsiveness, severe chest pain or collapse. Use available naloxone for suspected opioid overdose and follow the product instructions. Alcohol and sedatives can sharply increase risk with opioids or OUD medicines. After a period without opioids, tolerance can be lower, making return to previous use especially dangerous. Pregnancy, dehydration or uncontrolled withdrawal can require urgent assessment.
Ongoing visits review withdrawal, craving patterns, substance use, function and medication effects. Testing, when clinically appropriate, should help interpret the treatment picture; it is not a complete diagnosis by itself. Discuss whether the plan needs more support, a different formulation or another treatment setting. Effective medication may continue for a long time. Stopping requires a plan for relapse prevention and overdose safety.
Ask what the service actually provides: evaluation, ongoing prescribing, injections, counseling or referral. Confirm the specific location, appointment availability, fees and pharmacy or payer requirements. Same-day availability depends on assessment, the intended service and supply. If the requested medicine is unavailable, ask for a safe interim or referral plan rather than waiting without a next step.
Nao Medical offers assessment and follow-up for opioid use disorder, including buprenorphine treatment when clinically appropriate. Choose an addiction-care appointment and bring your current medicines and treatment history. If a pharmacy cannot fill a prescription, contact the prescriber and pharmacy promptly to discuss an appropriate alternative or transfer. Do not change the dose or use someone else’s medicine while waiting.
Have your insurance card ready when booking. Share member details through the clinic’s confirmed secure intake process. Check with the clinic and your insurer that the exact plan covers the clinician and requested service. Ask about visit charges, any separately billed tests or medicines, and any referral or authorization requirement. Coverage and your copay or deductible depend on the plan; request a written estimate if paying yourself.
An appropriate evaluation or follow-up may be possible by video when the clinician is authorized to treat you where you are physically located. The service must confirm age, eligibility and current prescribing requirements. A video visit does not guarantee a controlled-substance prescription. Some examinations and tests need an in-person visit. Provider-administered injections require the appropriate treatment setting. Ask intake where any ordered specimens must be collected. Tell intake your actual location and requested service.
Fentanyl-related opioid use disorder can be treated, including when you have struggled with earlier attempts to start medication. An evaluation reviews the actual use pattern, previous withdrawal or precipitated withdrawal, overdose risk and treatment preferences. The safest start cannot be guaranteed by waiting a fixed number of hours or copying a forum schedule.
Tell the clinician whether fentanyl was expected, whether exposure involved powders or pills and whether stimulants or other substances were also used. Describe past overdoses, treatment attempts and the last opioid exposure. Pregnancy, severe symptoms, breathing problems and sedating medicines influence the safest setting. A previous difficult initiation is important information rather than proof that treatment is impossible.
Bring any prior OUD prescription and describe what happened when it was started. Include the timing of symptoms, other opioids and whether an emergency visit was needed. The clinician uses this information and current assessment to plan care; a clock alone is not enough.
Discuss buprenorphine, a methadone program referral when appropriate, or naltrexone after suitable detoxification. A clinician may use an individualized initiation approach and decide where monitoring is needed. Follow the individualized initiation instructions from your clinician.
Oral buprenorphine, Sublocade and weekly or monthly Brixadi have different starting requirements. A long-acting injection is not automatically the first step for every patient. Confirm the product, the supervised assessment and the follow-up plan before administration.
Clarify pharmacy or injection access and what happens if symptoms persist or an appointment is missed. Have naloxone and teach trusted people how to respond. Address pain, sleep, mental health and practical barriers so treatment remains usable after the initial visit.
Call 911 for slow breathing, inability to wake, collapse or possible overdose. Give available naloxone according to its product instructions; repeat doses may be needed and emergency assessment remains necessary. Severe withdrawal, dehydration, chest pain or confusion needs timely assessment. Opioid tolerance can fall during a treatment gap or period without use, increasing danger if use resumes.
Manhattan
259 1st Ave, New York, NY 10003
A Manhattan location for addiction medicine visits, medication follow-up, and structured treatment planning.
View local MAT details Get directions